Lifetime Citizen Portal Access — AI Briefings, Alerts & Unlimited Follows
Supporters urge insurers to cover 12‑month contraception supply; insurers raise cost and dispensing concerns
Loading...
Summary
Supporters including medical associations and reproductive‑health groups told the House Health and Mental Health Committee that covering a year’s supply of self‑administered hormonal contraception would improve adherence and reduce unintended pregnancies; the Missouri Insurance Coalition opposed the bill citing cost concerns and uncertainties about pharmacy dispensing and refill statutes.
Supporters of House Bill 2,370 told the House Health and Mental Health Committee that requiring private insurers to allow patients to obtain a 12‑month supply of self‑administered hormonal contraception would reduce barriers to consistent use and lower unintended pregnancies, while an insurance‑industry witness warned of statutory and cost complications.
Representative Peters, sponsor of HB 2,370, said the bill would allow women to obtain a year’s supply at one time through private insurance, mirroring practices already available through Missouri Health Net. "Last year we made some headway — we could get 6 months in generics. We’re just asking again that women are allowed to have a year supply of contraception at a time," Peters said.
Elizabeth Grace Riley, representing the Missouri section of the American College of Obstetricians and Gynecologists, urged the committee to support the bill and described longer dispensing as an evidence‑based policy that improves health outcomes and reduces costs by removing refill barriers such as transportation and scheduling. "Coverage of an annual supply…is an evidence based policy that improves health outcomes, reduces costs, and removes unnecessary barriers to care," Riley said.
Opposition testimony from Hampton Williams of the Missouri Insurance Coalition focused on statutory and cost questions. Williams said the prior legislative change extended generics from 90 to 180 days and warned that brand‑name annual fills can be roughly six times more expensive. He also raised uncertainty about whether Missouri Health Net’s stated policy represents a bulk, single dispense or staggered fills over a year and pointed to pharmacist refill statutes as a potential mismatch with the bill's intent.
Committee members extensively questioned Williams about cost estimates, how often enrollees switch carriers within a year, and whether pharmacists’ authority to authorize refills (statute cited in testimony) would affect how an insurer must provide a 12‑month supply. Williams said he did not have carrier‑switching figures readily available and that the bill’s language could be read to require a single annual bulk dispense.
Other supporters included the Missouri State Medical Association (Rachel Bauer) and Beacon Reproductive Health Network (Riley Luckfield). Luckfield told the committee that Missouri Health Net’s website indicates it covers up to a year in one prescription fill for generic and brand products and cited studies showing increased adherence and reduced unintended pregnancy with year‑long dispensing. Dr. Jennifer Bean of MOST Policy Initiative provided data on rural care access and summarized evidence that 12‑month dispensing increases adherence and lowers unintended pregnancy rates.
The hearing concluded with no recorded committee vote; the bill will be carried forward through the legislative process for further consideration.
Key factual clarifications from testimony: Medicaid‑administered Missouri Health Net reportedly covers a 12‑month supply in a single pharmacy fill per its public materials; opponents say legal refill rules and plan design could affect how private carriers implement a year supply. The committee did not vote on HB 2,370 during the recorded session.
